Organon & Co.

NYSE:OGN

Pharmaceutical Preparations·JERSEY CITY, NJ

The Organon is the standard collection of Aristotle's six works on logical analysis and dialectic.

CEO

Morrissey Joseph T. Jr.

CFO

Walsh Matthew M

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	2/24/26	→
10-Q	Q3 2025	9/30/25	11/10/25	→
10-Q/A	Q2 2025	6/30/25	11/10/25	→
10-Q/A	Q1 2025	3/31/25	11/10/25	→
10-K/A	FY 2024	12/31/24	11/10/25	→
10-Q	Q2 2025	6/30/25	8/6/25	→
↓

Earnings Releases (8-K)

19 shown

Filed	Period
2/12/26	Q1 FY2026	→
11/10/25	Q4 FY2025	→
8/5/25	Q3 FY2025	→
5/1/25	Q2 FY2025	→
2/13/25	Q1 FY2025	→
10/31/24	Q3 FY2024	→
↓

News (8-K)

23 shown

Filed	Type	Description
2/20/26	Other	Other Events	→
11/7/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/30/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/27/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
6/12/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
5/27/25	Other	Other Events	→
↓

Prospectuses & Registrations

5 shown

Filed	Form	Description
6/13/25	S-8	S-8	→
4/25/25	ARS	ARS	→
4/25/24	ARS	ARS	→
4/27/23	ARS	ARS	→
6/3/21	S-8	S-8	→

Proxies

8 shown

Filed	Form	Description
4/25/25	DEFA14A	DEFA14A	→
4/25/25	DEF 14A	DEF 14A	→
4/25/24	DEFA14A	DEFA14A	→
4/25/24	DEF 14A	DEF 14A	→
4/27/23	DEFA14A	DEFA14A	→
4/27/23	DEF 14A	DEF 14A	→
↓

Filing History(397 filings)

TypeDateAccessionPeriodSize

Mar 3, 2026

0001628280-26-014231FORM 4

Feb 27, 2026

453.0 KB

Mar 3, 2026

0001628280-26-014228FORM 4

Feb 27, 2026

453.1 KB

Mar 3, 2026

0001628280-26-014226FORM 4

Feb 27, 2026

452.8 KB

Mar 3, 2026

0001628280-26-014224FORM 4

Feb 27, 2026

452.9 KB

Mar 3, 2026

0001628280-26-014222FORM 4

Feb 27, 2026

452.8 KB

Mar 3, 2026

0001628280-26-014211FORM 4

Feb 27, 2026

9.3 KB

10-K

Feb 24, 2026

0001628280-26-01112510-K

Dec 31, 2025

20.5 MB

8-K

Feb 20, 2026

0001104659-26-017870FORM 8-K

Feb 20, 2026

188.3 KB

8-K

Feb 12, 2026

0001104659-26-013888FORM 8-K

Feb 12, 2026

6.6 MB

4/A

Jan 16, 2026

0001628280-26-002406FORM 4/A

Nov 7, 2025

5.2 KB

Nov 17, 2025

0001628280-25-052592FORM 4

Nov 13, 2025

5.5 KB

Nov 17, 2025

0001628280-25-052590FORM 4

Nov 13, 2025

449.8 KB

Nov 13, 2025

0001628280-25-052004FORM 4

Nov 12, 2025

449.4 KB

Nov 12, 2025

0001628280-25-051733FORM 4

Nov 7, 2025

8.1 KB

Nov 12, 2025

0001628280-25-051731FORM 3

Oct 27, 2025

475.1 KB

Nov 10, 2025

0001628280-25-051052FORM 4

Nov 7, 2025

8.3 KB

Nov 10, 2025

0001628280-25-051009FORM 4

Nov 7, 2025

8.0 KB

10-Q

Nov 10, 2025

0001628280-25-05079510-Q

Sep 30, 2025

8.8 MB

8-K

Nov 10, 2025

0001104659-25-108821FORM 8-K

Nov 10, 2025

5.6 MB

10-Q/A

Nov 10, 2025

0001104659-25-10874010-Q/A

Jun 30, 2025

520.4 KB

10-Q/A

Nov 10, 2025

0001104659-25-10873210-Q/A

Mar 31, 2025

447.2 KB

10-K/A

Nov 10, 2025

0001104659-25-10869310-K/A

Dec 31, 2024

17.0 MB

8-K

Nov 7, 2025

0001104659-25-108130FORM 8-K

Nov 3, 2025

184.0 KB

Nov 6, 2025

0001628280-25-050186FORM 4

Nov 5, 2025

8.1 KB

8-K/A

Oct 30, 2025

0001104659-25-104442FORM 8-K/A

Oct 26, 2025

186.5 KB

25 filings shown

Filed	Form	Description
10/30/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
6/2/25	SD	FORM SD	→
4/30/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
5/28/24	SD	FORM SD	→
5/7/21	SEC STAFF LETTER	SEC STAFF LETTER	→
5/7/21	SEC STAFF ACTION	SEC STAFF ACTION	→
↓

Organon & Co.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Proxies

Filing History(397 filings)

Ownership

Other Filings

Filed	Form	Description
3/3/26	4	4	→
3/3/26	4	4	→
3/3/26	4	4	→
3/3/26	4	4	→
3/3/26	4	4	→
3/3/26	4	4	→
↓